Evotec announces that the Company has been selected as a winner of a 2023 CDMO Leadership Award across all the six core categories included in the award program including Capabilities, Compatibility, Expertise, Quality, Reliability and Service across two groups of respondents, Small Pharma, and Overall (combined Big and Small Pharma). Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/cdmo-leadership-awards-2023-6263